Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Postmarket policy considerations for biosimilar oncology drugs.
Renwick MJ, Smolina K, Gladstone EJ, Weymann D, Morgan SG. Renwick MJ, et al. Among authors: weymann d. Lancet Oncol. 2016 Jan;17(1):e31-8. doi: 10.1016/S1470-2045(15)00381-2. Epub 2015 Dec 23. Lancet Oncol. 2016. PMID: 26758759 Review.
29 results